+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 45Years
All Genders
ID07118059

Evaluating Omega-3 Fatty Acid Supplementation as an Addition to Treatment in Adults with Pulmonary Tuberculosis A Randomized Controlled Trial

Led by North-West University, South Africa · Updated on 2026-09-09

40

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adults aged 18 to 45 years with newly diagnosed, bacteriologically confirmed drug-sensitive pulmonary tuberculosis. This trial evaluates whether adding omega-3 long-chain polyunsaturated fatty acids n-3 LCPUFA to standard tuberculosis treatment can shorten the time it takes for sputum cultures to become positive, reduce inflammation, and improve treatment outcomes compared to a placebo. The study is a randomized controlled trial designed to assess early bactericidal activity, early inflammatory response, and safety of the supplementation. Participants are randomly assigned to receive either approximately 2 grams of omega-3 fatty acids EPA and DHA daily through three 1-gram fish oil capsules or a matching placebo of high linoleic sunflower oil capsules. This supplementation is given alongside the intensive phase of tuberculosis treatment for eight weeks. The study includes a parallel comparison between the omega-3 group and the placebo group. During the study, participants attend a baseline clinical visit followed by mostly weekly follow-up visits for two months, then monthly visits for four months during the continuous phase of tuberculosis treatment. They provide blood, sputum, and urine samples for biomarker and metabolomic analyses and undergo assessments of iron status, body composition, and muscle strength. Researchers measure sputum culture time to positivity at multiple points and monitor inflammatory markers, safety, and clinical outcomes throughout the trial.

CONDITIONS

Brief Title

Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial

Research Team

T

Tumelo Dr

Z

Ziska Pretorius, B. Cur

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here